Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | BMY | AMGN | GILD | VRTX |
| Company | Horizon Therapeutics | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 116.34 | 43.98 | 301.75 | 65.43 | 406.42 |
| High | 116.38 | 44.26 | 302.91 | 66.14 | 415.67 |
| Low | 116.26 | 43.84 | 298.51 | 65.16 | 394.03 |
| Last | 116.30 | 44.04 | 300.30 | 65.46 | 410.24 |
| Change | +0.05 | +0.14 | +0.82 | -0.08 | +7.74 |
| % Change | +0.04% | +0.32% | +0.27% | -0.12% | +1.92% |
| Volume | 28,881,200 | 10,914,947 | 2,436,425 | 7,193,109 | 1,604,085 |
| 20-Day Average Volume | 3,994,490 | 14,216,436 | 2,787,199 | 7,415,848 | 1,085,624 |
| Previous Close | 116.25 | 43.90 | 299.48 | 65.54 | 402.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 46.72 | 275.29 | 66.49 | 398.61 |
| 20-Day Raw Stochastic | 95.09% | 7.76% | 64.23% | 29.01% | 76.36% |
| 20-Day Relative Strength | 80.29% | 29.35% | 63.11% | 36.82% | 54.19% |
| Weighted Alpha | +49.30 | -36.28 | +28.21 | -19.39 | +17.80 |
| Today's Opinion | 88% Buy | 100% Sell | 40% Buy | 100% Sell | 32% Buy |
| Previous Opinion | 88% Buy | 100% Sell | 24% Buy | 100% Sell | 8% Buy |
| Last Month's Opinion | 40% Buy | 32% Sell | 24% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | +0.02% since 04/30/24 | +9.68% since 04/30/24 | +1.08% since 04/30/24 | +4.34% since 04/30/24 |
| Low | 115.66 on 09/29/23 | 43.33 on 05/02/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 392.47 on 05/01/24 |
| High | 116.38 on 10/05/23 | 44.62 on 05/06/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 415.67 on 05/07/24 |
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | -14.36% since 04/05/24 | +11.30% since 04/05/24 | -5.28% since 04/05/24 | +0.78% since 04/05/24 |
| Low | 114.75 on 09/11/23 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 116.38 on 10/05/23 | 51.68 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 415.67 on 05/07/24 |
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | -9.64% since 02/07/24 | +1.55% since 02/07/24 | -11.44% since 02/07/24 | -2.20% since 02/07/24 |
| Low | 98.80 on 08/03/23 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 116.38 on 10/05/23 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | -15.95% since 11/07/23 | +10.82% since 11/07/23 | -18.24% since 11/07/23 | +8.35% since 11/07/23 |
| Low | 90.56 on 05/16/23 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 116.38 on 10/05/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 88,989,688 | 160,633,888 | 81,602,352 | 104,029,752 |
| Shares Outstanding, K | 228,995 | 2,027,100 | 536,376 | 1,245,077 | 258,459 |
| Annual Sales | 3,629,040,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 521,480,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 944,960,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 127,070,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 1.03 | 0.45 | 0.60 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 11/01/23 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 41.90 | 16.71 | 16.07 | 29.84 |